DI
Therapeutic Areas
Roboscreen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Viral Pathogen Diagnostics (Hepatitis) | Hepatitis B, C, and Delta infection | Commercial |
| Neurodegenerative Disease Biomarker Assays | Alzheimer's, Parkinson's, CJD, BSE | Development/Commercial Launch |
| BD Tau Workflow | Alzheimer's Disease (e.g., pTau217 biomarker) | Commercial Launch |